Komori
Chiikishinbunsha (2164) · InitiativeAdvanced

Growth investment and strengthening of the financial base through a non-commitment rights offering

First written in FY2022. 8 of 14 entries say "Advanced", first in FY2023-Q3. Latest entry: 2026-10-20.

14entries
5years
6from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2022 – FY2023-Q1SoftenedFY2023 – FY2024-Q3AdvancedFY2025-H1 – 2026-04-302022: 12023: 320232024: 120242025: 220252026: 72026
Same theme, other companies
Capital Allocation to Growth Investments and Shareholder Returns under the Medium-Term Management PlanA theme 62 companies write about · 1 as a headwind · 68 as a tailwind

The whole theme swung hardest in 2026: 8 of 49 companies on the "Worse" side.

21 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 62 companies compared. The sentences above are computed from all 62.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1AdvancedAnnual report

    「With the steady progress of the “Strategic Plan,” the Company has reached the stage of making further growth investments. Accordingly, financing needs have arisen to advance this growth strategy. The funds are expected to be allocated to the following areas: ① maintaining and strengthening the distribution infrastructure for the free-paper publishing business, ② M&A-related expenses for building a regional co-creation platform, ③ investment in system development using generative AI technology, and ④ investment to improve management efficiency through consolidation of business locations and other measures.」

    For financing and growth investment, the Company expects to use the funds for specific purposes including distribution infrastructure, M&A for the regional co-creation platform, generative AI system development, and consolidation of business locations.
  2. FY2025AdvancedAnnual report

    「Cash flows from financing activities resulted in cash inflows of ¥947.802 million, primarily from long-term borrowings. This consisted mainly of ¥726.000 million in proceeds from long-term borrowings and ¥298.087 million in proceeds from the exercise of stock acquisition rights.」

    The Company recorded ¥298.087 million in proceeds from the exercise of stock acquisition rights, including those issued through the rights offering, and raised funds for growth investment and strengthening its financial base together with ¥726.000 million in long-term borrowings.
  3. FY2025-H1AdvancedAnnual report

    「During the interim accounting period, the Company raised ¥302.849 million through the non-committed rights offering.」

    The exercise of the seventh series of stock acquisition rights increased the number of shares outstanding by 1,070,138 and increased share capital and capital surplus by ¥151.424 million each. The rights offering progressed to the execution stage, and the Company raised ¥302.849 million during the interim accounting period. The intended use of proceeds was also changed, increasing the allocation to capital and business alliances and M&A from ¥165 million to ¥251 million, for a total of ¥431 million.
  4. FY2024-Q3ReframedAnnual report

    「Effective date of the free allotment of stock acquisition rights 12 July 2024 Amount raised ¥305,431,429 (estimated net proceeds: ¥285,431,429) Exercise period for stock acquisition rights 12 July 2024 to 11 September 2024 Uses of funds ① Capital and business alliances, M&A ② AI and software research and development ③ Expansion of resources」

    After the intended use of proceeds from the previous rights offering was reduced to ¥10 million, the Company resolved to conduct a new non-committed rights offering through its seventh series of stock acquisition rights. The estimated net proceeds of ¥285,431,429 were allocated to capital and business alliances and M&A, AI and software research and development, and expansion of resources.
  5. FY2023SoftenedAnnual report

    「Change pursuant to a resolution of the Company’s Board of Directors dated 10 July 2023 (After the change) Specific use of funds Amount ① Strengthening sales capabilities in areas expected to generate revenue ¥10 million ② Active promotion of DX-related businesses - ③ Development and initial investment in new businesses - ④ Funds for repayment of long-term borrowings to strengthen the financial base - Total ¥10 million」

    The intended use of proceeds from the rights offering was reduced from ¥275 million before the change to ¥10 million, with allocations to DX, new businesses and repayment of long-term borrowings reduced to zero. The commitments regarding the use of funds have weakened.
  6. FY2023-Q3AdvancedAnnual report

    「The exercise of stock acquisition rights resulted in the issuance of 54,919 new shares. Share capital and capital surplus each increased by ¥10.077 million, bringing share capital to ¥281.855 million and capital surplus to ¥211.855 million at the end of the fiscal year.」

    Regarding the non-committed rights offering, 54,919 shares were issued following the issuance of stock acquisition rights on 11 April 2023 and were exercised during the cumulative third quarter, increasing share capital and capital surplus by ¥10.077 million each. The Company also reported the exercise of 31,867 shares after the filing.
  7. FY2023-Q1RestatedAnnual report

    「As stated in the securities report for the previous fiscal year under “Significant Subsequent Events,” at a meeting of the Board of Directors held on 24 October 2022, the Company resolved to conduct a non-committed rights offering for all shareholders other than the Company itself. The proposal was submitted to and approved at the Company’s 38th annual general meeting of shareholders held on 24 November 2022. The effective date of the free allotment of the Company’s fifth series of stock acquisition rights to be issued through the non-committed rights offering was 11 April 2023.」

    The Company reconfirmed that the non-committed rights offering had been approved at the annual general meeting of shareholders and that the effective date of the free allotment of the fifth series of stock acquisition rights was 11 April 2023.
  8. FY2022First statedAnnual report

    「At a meeting of the Board of Directors held on 24 October 2022, the Company resolved to conduct a non-committed rights offering for all shareholders other than the Company itself, as described below.」

    Following the Board of Directors’ resolution on 24 October 2022 and approval at the annual general meeting of shareholders on 24 November, the Company presented a financing plan involving the free allotment of stock acquisition rights on 11 April 2023. The planned total number of stock acquisition rights was 2,072,033, with an exercise price based on ¥402 per right. The intended uses of funds were strengthening sales capabilities in areas expected to generate revenue, DX-related businesses, expanding the service areas of the newspaper and other publishing businesses, and repaying long-term borrowings.
Moved together

"Building Relationships with Local Governments and Expanding Public Administration-Related Business" moved the same way as this thread, in the same document, in 4 of its 14 moves.

444443★123456
  1. ★This thread
  2. 1Building Relationships with Local Governments and Expanding Public Administration-Related Business4×
  3. 2Business restructuring based on 5 medium-term management strategy initiatives4×
  4. 3Creating new value through new media, e-commerce, and proprietary databases, independent of publication frequency4×
  5. 4Enhancing Service Value and Creating New Revenue Streams through the DX Promotion Project4×
  6. 5Review of Distribution Areas, Selective Concentration of Management Resources, and Sales Optimization Through Division of Labor and Systems4×
  7. 6Introduction of Takeover Defense Measures Against Large-Scale Acquisition Activities3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Chiikishinbunsha's next results are scheduled for 2026-10-13. Read the earnings preview It last moved in the Governance of 2026-10-20: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Growth investment and strengthening of the financial base through a non-commitment rights offering | CHIIKISHINBUNSHA CO.,LTD. (2164) | Komori